Waldencast (NASDAQ:WALD) Shares Down 4.1%

Waldencast plc (NASDAQ:WALDGet Free Report) traded down 4.1% on Wednesday . The stock traded as low as $5.14 and last traded at $5.14. 1,109 shares were traded during mid-day trading, a decline of 98% from the average session volume of 69,398 shares. The stock had previously closed at $5.36.

Analyst Ratings Changes

Separately, Telsey Advisory Group lowered their price objective on Waldencast from $12.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 22nd.

Read Our Latest Analysis on Waldencast

Waldencast Price Performance

The company has a fifty day simple moving average of $6.62 and a two-hundred day simple moving average of $8.29.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Barclays PLC lifted its position in shares of Waldencast by 440.0% during the second quarter. Barclays PLC now owns 4,093 shares of the company’s stock worth $31,000 after purchasing an additional 3,335 shares in the last quarter. Amalgamated Bank raised its holdings in Waldencast by 68.1% in the third quarter. Amalgamated Bank now owns 3,277 shares of the company’s stock valued at $31,000 after acquiring an additional 1,328 shares in the last quarter. Norden Group LLC acquired a new stake in Waldencast in the first quarter valued at $92,000. State Board of Administration of Florida Retirement System acquired a new stake in Waldencast in the third quarter valued at $97,000. Finally, Simplicity Wealth LLC bought a new stake in Waldencast during the first quarter valued at $142,000. 41.97% of the stock is owned by institutional investors and hedge funds.

About Waldencast

(Get Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

Further Reading

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.